Diagnosis of mesothelioma may come months, years, or even decades after the exposure to asbestos. Though early diagnosis can improve treatment options and increase the chances of longevity, most victims will still face the tragic prognosis of an untimely death. According to new research, “biomarkers” could improve the accuracy of diagnoses for mesothelioma patients. Researchers who published the new study claim that an analysis of proteins and glycoproteins could save the lives of patients.
Doctors, hospitals, and medical researchers are always exploring new ways to better diagnose and treat patients. According to a recent study, using more biomarkers can improve accuracy in diagnosis. The study was published in the recent issue of Anticancer Research. Our Boston mesothelioma lawyers are dedicated to helping victims recover the compensation they deserve after diagnosis. We also help families of victims make legal claims if they have lost a loved one to mesothelioma. In addition to providing legal support, our team is committed to staying abreast of medical developments and informing clients about breakthroughs in mesothelioma treatment.
Continue reading